Physician profile
April E Thomas
NPI 1568930527
$4,073.03
in general payments reported to CMS, 2019-2025
28 companies · $785 in 2025
The $785 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $885 · 2022: $766 · 2023: $532 · 2024: $1,104 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,421.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,035.79 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Si-Bone, INC. | $461.01 | 2022-2025 | |
| Saluda Medical Americas, INC. | $400.19 | 2024-2025 | Evoke |
| Abbott Laboratories | $353.12 | 2023-2024 | Eterna, Proclaim |
| Boston Scientific Corporation | $351.29 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Biohaven Pharmaceuticals, INC. | $280.05 | 2021 | |
| Abbvie INC. | $166.09 | 2021-2024 | |
| Vertex Pharmaceuticals Incorporated | $139.23 | 2025 | |
| Globus Medical, INC. | $129.80 | 2025 | Senza |
| Spr Therapeutics, INC | $125.33 | 2022-2025 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $111.77 | 2021 | |
| Almatica Pharma LLC | $84.68 | 2021 | |
| Novartis Pharmaceuticals Corporation | $74.79 | 2021 | |
| Nevro Corp. | $52.64 | 2022-2023 | Senza |
| Davol INC. | $47.50 | 2024 | Arista Ah Flexitip |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $36.07 | 2021 | |
| Lilly USA, LLC | $26.85 | 2021 | |
| Vertos Medical, INC. | $26.69 | 2021 | |
| Allergan, INC. | $24.81 | 2021 | |
| Baudax Bio INC. | $22.30 | 2021 | |
| Endo Pharmaceuticals INC. | $20.73 | 2023 | Xiaflex |
| Stryker Corporation | $16.93 | 2025 | Mild Device Kit |
| Forte Bio-Pharma LLC | $16.70 | 2021 | |
| Redhill Biopharma INC. | $15.40 | 2021 | |
| Avanos Medical | $14.33 | 2022 | |
| Philips North America LLC | $13.83 | 2023 | |
| Arbor Pharmaceuticals, INC. | $12.75 | 2021 | |
| Ibsa Pharma INC. | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.